Peripheral blood hematopoietic stem and progenitor cell frequency is unchanged in patients with alpha-1-antitrypsin deficiencyde Kruijf, E-J. F. M., Alkemade, G. M., van Os, R., Fibbe, W. E. & van Pel, M., Jun-2014, In : International journal of hematology. 99, 6, p. 714-720 7 p.
Research output: Contribution to journal › Article › Academic › peer-review
Granulocyte-colony-stimulating factor (G-CSF)-induced hematopoietic stem and progenitor cell (HSPC) mobilization is associated with the release of neutrophil-derived proteases. Previously, we have shown that alpha-1-antitrypsin (AAT) inhibits these proteases in mice, resulting in inhibition of HSPC mobilization. Here, we studied the relationship between AAT and HSPC in steady state and cytokine-induced mobilization in humans. Patients with alpha-1-antitrypsin deficiency (AATD) have an 85-90 % decrease of AAT in the peripheral blood (PB). We hypothesized that this leads to increased proteolytic activity in the bone marrow and increased steady-state PB HSPC numbers. Using flow cytometry and semi-solid cell culture, we found no significant difference in PB HSPC in AATD patients (n = 18) as compared to controls (n = 22). Healthy stem cell donors (n = 43) were mobilized with G-CSF for 5 days and the number of CD45(+)/CD34(+) HSPC were determined in PB. We found that, during mobilization, PB AAT levels increased significantly, positively correlating with PB CD45(+)/CD34(+) cells (r = 0.31, p = 0.005). In conclusion, although serum AAT levels and HSPC mobilization in healthy stem cell donors are positively correlated, AAT is not an indispensable protease-inhibitor in the constitutive circulation of HSPC. These findings suggest a model in which both protease-dependent and -independent pathways contribute to HSPC mobilization.
|Number of pages||7|
|Journal||International journal of hematology|
|Publication status||Published - Jun-2014|
- Stem cells, Alpha-1-antitrypsin deficiency, Hematopoietic stem cell mobilization, Granulocyte-colony-stimulating factor, COLONY-STIMULATING FACTOR, BONE-MARROW, G-CSF, ALPHA(1)-ANTITRYPSIN DEFICIENCY, GELATINASE-B, MOBILIZATION, MICE, CYCLOPHOSPHAMIDE, EXPRESSION, INHIBITOR